Cabozantinib in Progressive Medullary Thyroid Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cabozantinib in Progressive Medullary Thyroid Cancer
J. Clin. Oncol 2013 Sep 03;[EPub Ahead of Print], R Elisei, MJ Schlumberger, SP Müller, P Schöffski, MS Brose, MH Shah, L Licitra, B Jarzab, V Medvedev, MC Kreissl, B Niederle, EE Cohen, LJ Wirth, H Ali, C Hessel, Y Yaron, D Ball, B Nelkin, SI ShermanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.